Saudi Pharmaceutical Industries and Medical Appliances Corporation Stock

Equities

2070

SA0007879188

Pharmaceuticals

End-of-day quote Saudi Arabian S.E. 06:00:00 2024-04-21 pm EDT 5-day change 1st Jan Change
37.85 SAR -1.69% Intraday chart for Saudi Pharmaceutical Industries and Medical Appliances Corporation +3.42% +0.13%
Sales 2024 * 1.92B 513M Sales 2025 * 2.12B 564M Capitalization 4.54B 1.21B
Net income 2024 * 112M 29.88M Net income 2025 * 171M 45.61M EV / Sales 2024 * 2.85 x
Net Debt 2024 * 940M 251M Net Debt 2025 * 819M 218M EV / Sales 2025 * 2.53 x
P/E ratio 2024 *
41 x
P/E ratio 2025 *
26.8 x
Employees -
Yield 2024 *
0.96%
Yield 2025 *
2.14%
Free-Float 79.51%
More Fundamentals * Assessed data
Dynamic Chart
Saudi Pharmaceutical Industries And Medical Appliances Plans Not to Distribute FY23 Dividends MT
Saudi Pharmaceutical Industries And Medical Appliances Logs Narrower FY23 Net Loss; Revenue Up MT
Saudi Pharmaceutical Industries and Medical Appliances Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Saudi Pharmaceutical Industries and Medical Appliances Corporation Appoints Jerome Cabannes as Chief Executive Officer CI
Saudi Pharmaceutical Industries and Medical Appliances Corporation Appoints Atef Zouari as Chief Financial Officer CI
Saudi Pharmaceutical Industries and Medical Appliances Corporation Appoints Abdullah Al-Rashidi as Chief Operating Officer CI
Saudi Pharmaceutical Industries and Medical Appliances Corporation acquired 15% stake in Dammam Pharmaceutical from Cooper Pharma for SAR 27 million. CI
Sigma Pharmaceutical Industries SAE and Ahmed Abd El Monem Aly Habib signed a share purchase agreement to acquire 76.4% stake in Spimaco Misr for Marketing Company from Saudi Pharmaceutical Industries and Medical Appliances Corporation. CI
Saudi Pharmaceutical Industries and Medical Appliances Corporation agreed to acquire 68% stake in Osmopharm SA for SAR 16.1million. CI
Saudi Pharmaceutical Industries and Medical Appliances Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Saudi Pharmaceutical Industries and Medical Appliances Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Saudi bourse gains, Dubai extends losses ahead of U.S. debt-limit talks RE
Saudi Pharmaceutical Industries and Medical Appliances Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Saudi Pharmaceutical Industries and Medical Appliances Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Saudi Pharmaceutical Industries and Medical Appliances Corp. Announces the Signing of A Credit Facility Agreement (Sharia Compliant) with SABB Bank CI
More news
1 day-1.69%
1 week+3.42%
Current month+6.92%
1 month-6.54%
6 months+30.52%
Current year+0.13%
More quotes
1 week
35.55
Extreme 35.55
38.70
1 month
33.25
Extreme 33.25
41.55
Current year
32.85
Extreme 32.85
42.85
1 year
24.86
Extreme 24.86
45.25
3 years
21.02
Extreme 21.02
61.40
5 years
21.02
Extreme 21.02
61.40
10 years
21.02
Extreme 21.02
61.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - 21-01-04
Director of Finance/CFO - 22-04-30
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 67 18-12-31
Director/Board Member - 16-04-02
Director/Board Member - 20-02-07
More insiders
Date Price Change Volume
24-04-22 37.85 -1.69% 919,408
24-04-21 38.5 +2.12% 1,663,467
24-04-18 37.7 +4.87% 1,270,432
24-04-17 35.95 -1.10% 665,356
24-04-16 36.35 -0.68% 752,188

End-of-day quote Saudi Arabian S.E., April 21, 2024

More quotes
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC (SPIMACO) is a Saudi Arabia-based company engaged in the pharmaceutical industry sector. The Company is organized, together with its subsidiaries, into two business segments: the Medical and pharmaceutical production segment focuses on the manufacture, production, development and marketing of pharmaceutical raw materials and medical appliances, as well as the production of consumables medical appliances, and the Investment segment is engaged in investing activity in associates and investment in securities. The Company’s product pipeline includes tablets, capsules, dry powder for suspension, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Company’s manufacturing facility is located at Qassim Industrial City, about 320 kilometers north-west of Riyadh.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
37.85 SAR
Average target price
35.48 SAR
Spread / Average Target
-6.26%
Consensus

Quarterly revenue - Rate of surprise